T H LeJemtel - JoVE Visualize

Showing results (71-80 of 96) with videos related to

Pageof 10

Sort By:

Circulation|January 13, 1999

Sustained improvement in flow-mediated vasodilation after short-term administration of dobutamine in patients with severe congestive heart failureM B Patel, I V Kaplan, R N Patni, et al.

Journal of the American College of Cardiology|July 14, 2001

Physical training in patients with chronic heart failure enhances the expression of genes encoding antioxidative enzymesP V Ennezat, S L Malendowicz, M Testa, et al.

Journal of the American College of Cardiology|November 1, 1993

Regional specificity of peak hyperemic response in patients with congestive heart failure: correlation with peak aerobic capacityG Jondeau, S D Katz, J F Toussaint, et al.

Journal of the American College of Cardiology|July 10, 1999

Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study GroupR M Mills, T H LeJemtel, D P Horton, et al.

Circulation|April 1, 1997

Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failureL Demopoulos, M Yeh, M Gentilucci, et al.

The American Journal of Medicine|July 1, 1980

The demonstration of vegetations by echocardiography in bacterial endocarditis. An indication for early surgical interventionR S Davis, J A Strom, W Frishman, et al.

The American Journal of Cardiology|December 11, 1991

Initial blood pressure response to enalapril in hospitalized patients (Studies of Left Ventricular Dysfunction [SOLVD])W B Hood, M Youngblood, J K Ghali, et al.

American Heart Journal|November 1, 1983

Improvement in exercise capacity despite cardiac deteriora tion: nonivasive assessment of long-term therapy with amrinone in severe heart failureL A Siegel, T H LeJemtel, J Strom, et al.

Journal of Cardiovascular Pharmacology|October 23, 1997

Angiotensin II-receptor blockade further reduces afterload safely in patients maximally treated with angiotensin-converting enzyme inhibitors for heart failureG Hamroff, I Blaufarb, D Mancini, et al.

Circulation|June 1, 1979

Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in manT H LeJemtel, E Keung, E H Sonnenblick, et al.

Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:

Pageof 10

Circulation|January 13, 1999

Sustained improvement in flow-mediated vasodilation after short-term administration of dobutamine in patients with severe congestive heart failureM B Patel, I V Kaplan, R N Patni, et al.

Journal of the American College of Cardiology|July 14, 2001

Physical training in patients with chronic heart failure enhances the expression of genes encoding antioxidative enzymesP V Ennezat, S L Malendowicz, M Testa, et al.

Journal of the American College of Cardiology|November 1, 1993

Regional specificity of peak hyperemic response in patients with congestive heart failure: correlation with peak aerobic capacityG Jondeau, S D Katz, J F Toussaint, et al.

Journal of the American College of Cardiology|July 10, 1999

Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study GroupR M Mills, T H LeJemtel, D P Horton, et al.

Circulation|April 1, 1997

Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failureL Demopoulos, M Yeh, M Gentilucci, et al.

The American Journal of Medicine|July 1, 1980

The demonstration of vegetations by echocardiography in bacterial endocarditis. An indication for early surgical interventionR S Davis, J A Strom, W Frishman, et al.

The American Journal of Cardiology|December 11, 1991

Initial blood pressure response to enalapril in hospitalized patients (Studies of Left Ventricular Dysfunction [SOLVD])W B Hood, M Youngblood, J K Ghali, et al.

American Heart Journal|November 1, 1983

Improvement in exercise capacity despite cardiac deteriora tion: nonivasive assessment of long-term therapy with amrinone in severe heart failureL A Siegel, T H LeJemtel, J Strom, et al.

Journal of Cardiovascular Pharmacology|October 23, 1997

Angiotensin II-receptor blockade further reduces afterload safely in patients maximally treated with angiotensin-converting enzyme inhibitors for heart failureG Hamroff, I Blaufarb, D Mancini, et al.

Circulation|June 1, 1979

Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in manT H LeJemtel, E Keung, E H Sonnenblick, et al.

Pageof 10